本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enanta Pharmaceuticals Inc.

12.96
+0.26002.05%
成交量:28.91萬
成交額:372.10萬
市值:3.76億
市盈率:-5.53
高:13.04
開:12.83
低:12.59
收:12.70
52周最高:17.15
52周最低:7.05
股本:2,901.85萬
流通股本:2,251.30萬
量比:1.27
換手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-2.3416
每股收益(LYR):-3.8381
淨資產收益率:-70.12%
總資產收益率:-12.28%
市淨率:3.72
市盈率(LYR):-3.38

資料載入中...

2021/01/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/04

重要事件披露

8-K - Current report
2020/11/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/11/23

重要事件披露

8-K - Current report
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/04

重要事件披露

8-K - Current report
2020/06/30

重要事件披露

8-K - Current report
2020/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/03/04

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/02

重要事件披露

Current report, item 5.07
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/02/06

重要事件披露

Current report, items 2.02 and 9.01
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/23

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals